$30.14 +0.39 (%) Sarepta Therapeutics Inc - NASDAQ

Jul. 2, 2015 | 04:00 PM

Partner Headlines

  1. 2 DMD drugs make progress

    IBD | Jun. 29, 2015 | 18:45PM EST
  2. BioMarin, Sarepta Muscular Dystrophy Drugs Progress

    IBD | Jun. 29, 2015 | 10:18AM EST
  3. Sarepta Therapeutics Completes NDA Submission to FDA for Eteplirsen for the Treatment of Duchenne Muscular Dystrophy Amenable to Exon 51 Skipping

    Benzinga | Jun. 29, 2015 | 07:01AM EST
  4. Benzinga's Top Upgrades

    Benzinga | Jun. 22, 2015 | 09:07AM EST
  5. Benzinga's Top Downgrades

    Benzinga | May. 21, 2015 | 08:50AM EST
  6. Sarepta Therapeutics Inc (SRPT) Will File NDA; Analysts Have Mixed Ratings

    GuruFocus | May. 20, 2015 | 19:28PM EST
  7. Wednesday's Pre-Market Insights: Yahoo! Inc. ...

    GuruFocus | May. 20, 2015 | 18:24PM EST
  8. Sarepta Soars On New Hope For Muscular-Dystrophy Drug

    IBD | May. 20, 2015 | 11:45AM EST
  9. Benzinga's Volume Movers

    Benzinga | May. 20, 2015 | 10:23AM EST
  10. Benzinga's Top Upgrades

    Benzinga | May. 20, 2015 | 09:16AM EST
  11. Stock Futures Aim For Mixed Open; Sarepta Soars, Etsy Heads South

    IBD | May. 20, 2015 | 09:06AM EST
  12. SunTrust Robinson Humphrey Upgrades Sarepta Therapeutics To Buy

    Benzinga | May. 20, 2015 | 08:58AM EST
  13. Benzinga's Top Upgrades

    Benzinga | May. 6, 2015 | 09:04AM EST
  14. Steven Cohen Keeps on Buying Biotechnological Companies

    GuruFocus | May. 4, 2015 | 18:48PM EST
  15. Why Muscular Dystrophy Is Biotech's Favorite Orphan

    IBD | Feb. 19, 2015 | 16:59PM EST
  16. Bank Of America Upgrades Sarepta Therapeutics On 'Increased Conviction' Of Drug Approval

    Benzinga | Feb. 17, 2015 | 13:54PM EST
  17. Top 5 Biotech Stocks That The Smart Money Doesn't Like

    Benzinga | Feb. 17, 2015 | 12:17PM EST
  18. Who Ignited The Rally In Sarepta Therapeutics?

    Benzinga | Feb. 17, 2015 | 12:13PM EST
  19. 10 Biotech Stories You Might've Missed This Week

    Benzinga | Jan. 15, 2015 | 13:18PM EST
  20. Biotechs Presenting At The J.P. Morgan Healthcare Conference: Day 4

    Benzinga | Jan. 13, 2015 | 11:34AM EST
  21. Big Short Interest On These 5 Biotech Stocks

    Benzinga | Jan. 12, 2015 | 15:36PM EST
  22. Mid-Day Market Update: Foundation Medicine Shares Jump Following Deal With Roche; Crude Oil Slides Over 4%

    Benzinga | Jan. 12, 2015 | 12:55PM EST
  23. Mid-Morning Market Update: Markets Tumble; Shire To Acquire NPS Pharmaceuticals For $5.2 Billion

    Benzinga | Jan. 12, 2015 | 11:37AM EST
  24. Morning Market Losers

    Benzinga | Jan. 12, 2015 | 09:54AM EST
  25. Merger Monday Moving Stocks Monday Morning

    Benzinga | Jan. 12, 2015 | 09:48AM EST
  26. Benzinga's Top #PreMarket Losers

    Benzinga | Jan. 12, 2015 | 08:15AM EST
  27. Sarepta Therapeutics Falls Following 6-Minute Walk Test Results

    Benzinga | Jan. 12, 2015 | 08:13AM EST
  28. Viral Investing: Ebola Drug Makers' Varied Strategies

    IBD | Dec. 26, 2014 | 16:09PM EST
  29. Stocks Hitting 52-Week Lows

    Benzinga | Dec. 12, 2014 | 10:09AM EST
  30. Market Mixed Amid Plan To Spend $300 Million On Ebola Vaccines

    Benzinga | Dec. 11, 2014 | 14:14PM EST
  31. BioMarin Buying Prosensa, Backing Up Troubled Drug

    IBD | Nov. 24, 2014 | 10:22AM EST
  32. Morning Market Movers

    Benzinga | Nov. 24, 2014 | 09:46AM EST
  33. Sarepta Therapeutics Shares Trending Higher Amid Sector M&A

    Benzinga | Nov. 24, 2014 | 09:20AM EST
  34. Stock Futures Trending Higher; Kate Spade Bags An Upgrade

    IBD | Nov. 24, 2014 | 09:19AM EST
  35. Benzinga's Top #PreMarket Gainers

    Benzinga | Nov. 24, 2014 | 08:10AM EST
  36. Investors Rewarded With Treats, Not Tricks, As Dow And S&P Close At Records High

    Benzinga | Oct. 31, 2014 | 16:54PM EST
  37. Morning Market Movers

    Benzinga | Oct. 31, 2014 | 09:55AM EST
  38. Benzinga's Top #PreMarket Gainers

    Benzinga | Oct. 31, 2014 | 08:15AM EST
  39. Ebola Vaccine Contenders

    Benzinga | Oct. 30, 2014 | 10:44AM EST
  40. Markets Continue To Rally As The Dow Closes Above 17,000

    Benzinga | Oct. 28, 2014 | 16:44PM EST
  41. Baird Downgrades Sarepta Therapeutics To Neutral

    Benzinga | Oct. 28, 2014 | 07:54AM EST
  42. Fast Money Traders Discuss Merck, Garmin And Sarepta Therapeutics

    Benzinga | Oct. 27, 2014 | 20:18PM EST
  43. Sarepta tumbles on drug delay

    IBD | Oct. 27, 2014 | 18:55PM EST
  44. Markets Virtually Flat, Oil Continues To Decline Following Bearish Outlook

    Benzinga | Oct. 27, 2014 | 16:58PM EST
  45. Mid-Afternoon Market Update: NQ Mobile Climbs On SEC Filing; Huntsman Shares Slide

    Benzinga | Oct. 27, 2014 | 15:15PM EST
  46. Sarepta Gets Delayed And The Stock Gets Drilled

    Benzinga | Oct. 27, 2014 | 14:51PM EST
  47. Mid-Day Market Update: Micron Gains On Buyback Announcement; Sarepta Shares Dip

    Benzinga | Oct. 27, 2014 | 12:41PM EST
  48. Mid-Morning Market Update: Markets Down; Merck Posts Upbeat Earnings

    Benzinga | Oct. 27, 2014 | 11:12AM EST
  49. Morning Market Losers

    Benzinga | Oct. 27, 2014 | 10:07AM EST
  50. Benzinga's Top #PreMarket Losers

    Benzinga | Oct. 27, 2014 | 08:21AM EST
Trading Center
×

You are using adblocking software

Want access to all of Investopedia? Add us to your “whitelist”
so you'll never miss a feature!